Faster Delivery for Induction With Misoprostol Plus Cervical Foley

Share this content:
Faster Delivery for Induction With Misoprostol Plus Cervical Foley
Faster Delivery for Induction With Misoprostol Plus Cervical Foley

THURSDAY, Nov. 10, 2016 (HealthDay News) -- For women undergoing induction, receipt of misoprostol-cervical Foley is associated with an increased likelihood of delivery before those receiving either method alone, according to a study published in the December issue of Obstetrics & Gynecology.

Lisa D. Levine, M.D., from the University of Pennsylvania Perelman School of Medicine in Philadelphia, and colleagues conducted a randomized trial comparing four induction methods: misoprostol alone, Foley alone, misoprostol-cervical Foley concurrently, and Foley-oxytocin concurrently. To compare the groups pairwise, a sample size of 123 per group was planned (492 patients overall); 491 were randomized and analyzed.

The researchers found that combination methods achieved a faster median time to delivery than single-agent methods (misoprostol-Foley, 13.1 hours; Foley-oxytocin, 14.5 hours; misoprostol, 17.6 hours; and Foley, 17.7 hours; P < 0.001). Women who received misoprostol-Foley were almost twice as likely to deliver before those who received misoprostol alone and Foley alone after censoring for cesarean delivery and adjusting for parity (hazard ratios, 1.92 and 1.87, respectively); there was no significant difference for Foley-oxytocin versus single-agent methods.

"After censoring for cesarean delivery and adjusting for parity, misoprostol-cervical Foley resulted in twice the chance of delivering before either single-agent method," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Alzheimer's Mortality Up 55 Percent From 1999 to 2014

CDC: Alzheimer's Mortality Up 55 Percent From 1999 ...

More patients also dying at home, with the caregiving burden often falling on loved ones

Targeting ANGPTL3 Can Significantly Lower Cholesterol

Targeting <i>ANGPTL3</i> Can Significantly Lower Cholesterol

Two trials show promise for non-statin approach to cardiovascular disease prevention

Factors Raise Risk of Pregnancy-Related Stroke in Preeclampsia

Factors Raise Risk of Pregnancy-Related Stroke in Preeclampsia

Infections, clotting disorders, chronic hypertension all found to increase risk

is free, fast, and customized just for you!

Already a member?

Sign In Now »